Citrate occurs widely in healthy and pathological apatitic biomineral: Mineralized articular cartilage, and intimal atherosclerotic plaque and apatitic kidney stones

Calcified Tissue International

Volumn 93, Issue 3, 2013, Pages 253-260

  Reid, David G ^a   Duer, Melinda J ^a   Jackson, Graham E ^b   Murray, Rachel C ^c   Rodgers, Allen L ^b   Shanahan, Catherine M ^d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ANIMAL HEALTH TRUST   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Apatite; Atherosclerotic plaque; Biomineralization; Brushite; Mineralized cartilage; Urolithiasis

Indexed keywords

APATITE; CALCIUM PHOSPHATE; CITRIC ACID; GLYCOSAMINOGLYCAN;

ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; ATHEROSCLEROTIC PLAQUE; BIOGENESIS; BIOMINERALIZATION; BONE STRUCTURE; CALCIFICATION; CARBON NUCLEAR MAGNETIC RESONANCE; CYTOLOGY; HORSE; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; MINERALIZATION; NEPHROLITHIASIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TISSUE METABOLISM; TISSUE STRUCTURE;

ANIMALS; APATITES; CALCIFICATION, PHYSIOLOGIC; CALCINOSIS; CALCIUM PHOSPHATES; CARTILAGE, ARTICULAR; CITRIC ACID; HORSES; HUMANS; KIDNEY CALCULI; MAGNETIC RESONANCE SPECTROSCOPY; NEPHROLITHIASIS; PLAQUE, ATHEROSCLEROTIC; TUNICA INTIMA;

EID: 84882455961     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-013-9751-5     Document Type: Article

References (45)

1. Dickens F (1941) The citric acid content of animal tissues with reference to its occurrence in bone and tumour. Biochem J 35:1011-1023
2. Taylor TG (1960) The nature of bone citrate. Biochim Biophys Acta 39:148-149
3. Huggins C, Bear RS (1944) The course of the prostatic ducts and the anatomy, chemical and X-ray diffraction analysis of prostatic calculi. J Urol 51:37-47
4. Hu YY, Rawal A, Schmidt-Rohr K (2010) Strongly bound citrate stabilizes the apatite nanocrystals in bone. Proc Natl Acad Sci USA 107:22425-22429
5. Lopez-Macipe A, Gomez-Morales J, Rodriguez-Clemente R (1998) Nanosized hydroxyapatite precipitation from homogeneous calcium/citrate/phosphate solutions using microwave and conventional heating. Adv Mater 10:49-53
6. Lopez-Macipe A, Gomez-Morales J, Rodriguez-Clemente R (1998) The role of pH in the adsorption of citrate ions on hydroxyapatite. J Colloid Interface Sci 200:114-120
7. Schneiders W, Reinstorf A, Pompe W, Grass R, Biewener A, Holch M, Zwipp H, Rammelt S (2007) Effect of modification of hydroxyapatite/collagen composites with sodium citrate, phosphoserine, phosphoserine/RGD-peptide and calcium carbonate on bone remodelling. Bone 40:1048-1059
8. Rhee SH, Tanaka J (1999) Effect of citric acid on the nucleation of hydroxyapatite in a simulated body fluid. Biomaterials 20:2155-2160
9. Hu YY, Liu XP, Ma X, Rawal A, Prozorov T, Akinc M, Mallapragada SK, Schmidt-Rohr K (2011) Biomimetic self-assembling copolymer-hydroxyapatite nanocomposites with the nanocrystal size controlled by citrate. Chem Mater 23:2481-2490
10. Johnsson MSA, Richardson CF, Sharma VK, Sallis JD, Nancollas GH (1990) Phosphocitrate and citrate effects on calcium-phosphate crystal-growth. J Dent Res 69:119
11. Sharma VK, Johnsson M, Sallis JD, Nancollas GH (1992) Influence of citrate and phosphocitrate on the crystallization of octacalcium phosphate. Langmuir 8:676-679
12. Legeros RZ, Daculsi G, Orly I, Abergas T, Torres W (1989) Solution-mediated transformation of octacalcium phosphate (OCP) to apatite. Scanning Micros 3:129-138
13. Xie BQ, Nancollas GH (2010) How to control the size and morphology of apatite nanocrystals in bone. Proc Natl Acad Sci USA 107:22369-22370
14. Wu YJ, Tsai TWT, Chan JCC (2012) Asymmetric crystal morphology of apatite induced by the chirality of dicarboxylate additives. Cryst Growth Des 12:547-549
15. Cheung HS, Kurup IV, Sallis JD, Ryan LM (1996) Inhibition of calcium pyrophosphate dihydrate crystal formation in articular cartilage vesicles and cartilage by phosphocitrate. J Biol Chem 271:28082-28085
16. Robinson MR, Leitao VA, Haleblian GE, Scales CD, Chandrashekar A, Pierre SA, Prerninger GM (2009) Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation. J Urol 181:1145-1150
17. Greischar A, Nakagawa Y, Coe FL (2003) Influence of urine pH and citrate concentration on the upper limit of metastability for calcium phosphate. J Urol 169:867-870
18. Mattle D, Hess B (2005) Preventive treatment of nephrolithiasis with alkali citrate - a critical review. Urol Res 33:73-79
19. Delgado-Lopez JM, Iafisco M, Rodriguez I, Tampieri A, Prat M, Gomez-Morales J (2012) Crystallization of bioinspired citrate-functionalized nanoapatite with tailored carbonate content. Acta Biomater 8:3491-3499
20. Chow K, Dixon J, Gilpin S, Kavanagh JP, Rao PN (2004) Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones. Kidney Int 65:1724-1730
21. 31P NMR analysis of urinary stones. J Urol 164:856-863
22. Duer MJ, Friscic T, Proudfoot D, Reid DG, Schoppet M, Shanahan CM, Skepper JN, Wise ER (2008) Mineral surface in calcified plaque is like that of bone: further evidence for regulated mineralization. Arterioscler Thromb Vasc Biol 28:2030-2034
23. Reid DG, Jackson GJ, Duer MJ, Rodgers AL (2011) Apatite in kidney stones is a molecular composite with glycosaminoglycans and proteins: evidence from nuclear magnetic resonance spectroscopy, and relevance to Randall's plaque, pathogenesis and prophylaxis. J Urol 185:725-730
24. Bradley JV, Bridgland LN, Colyer DE, Duer MJ, Frišč ić T, Gallagher JR, Reid DG, Skepper JN, Trasler CM (2010) NMR of biopolymer-apatite composites: developing a model of the molecular structure of the mineral-matrix interface in calcium phosphate biomaterials. Chem Mater 22:6109-6116
25. Duer MJ, Friscic T, Murray RC, Reid DG, Wise ER (2009) The mineral phase of calcified cartilage: its molecular structure and interface with the organic matrix. Biophys J 96:3372-3378
26. Reid DG, Shanahan CM, Duer MJ, Arroyo LG, Schoppet M, Brooks RA, Murray RC (2012) Lipids in biocalcification: contrasts and similarities between intimal and medial vascular calcification and bone by NMR. J Lipid Res 53:1569-1575
27. Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, Inoue K, Okumura M, Ishii J, Anno H, Virmani R, Ozaki Y, Hishida H, Narula J (2007) Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 50:319-326
28. Guo W, Morrisett JD, DeBakey ME, Lawrie GM, Hamilton JA (2000) Quantification in situ of crystalline cholesterol and calcium phosphate hydroxyapatite in human atherosclerotic plaques by solid-state magic angle spinning NMR. Arterioscler Thromb Vasc Biol 20:1630-1636
29. Anderson HC (1983) Calcific diseases. A concept. Arch Pathol Lab Med 107:341-348
30. Sage AP, Tintut Y, Demer LL (2010) Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 7:528-536
31. Jehle S, Hulter HN, Krapf R (2013) Effect of potassium citrate on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 98:207-217
32. Johnsson MSA, Nancollas GH (1992) The role of brushite and octacalcium phosphate in apatite formation. Crit Rev Oral Biol Med 3:61-82
33. Wang L, MNancollas GH (2009) Calcium orthophosphates: crystallization and dissolution. Chem Rev 108:4628-4669
34. Rodgers AL, Allie-Hamdulay S, Jackson G, Tiselius HG (2011) Simulating calcium salt precipitation in the nephron using chemical speciation. Urol Res 39:245-251
35. Jiang WG, Chu XB, Wang B, Pan HH, Xu XR, Tang RK (2009) Biomimetically triggered inorganic crystal transformation by biomolecules: a new understanding of biomineralization. J Phys Chem B 113:10838-10844
36. Morton AR, Iliescu EA, Wilson JW (2002) Nephrology: 1. Investigation and treatment of recurrent kidney stones. Can Med Assoc J 166:213-218
37. 2O) transformation in DMEM solutions at 36.5 C. Mater Sci Eng C Mater Biol Appl 30:245-254
38. Tseng YH, Mou CY, Chan JC (2006) Solid-state NMR study of the transformation of octacalcium phosphate to hydroxyapatite: a mechanistic model for central dark line formation. J Am Chem Soc 128:6909-6918
39. Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576-591
40. Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE (2004) Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 66:777-785
41. Pramanik R, Asplin JR, Jackson ME, Williams JC Jr (2008) Protein content of human apatite and brushite kidney stones: significant correlation with morphologic measures. Urol Res 36:251-258
42. Krambeck AE, Handa SE, Evan AP, Lingeman JE (2010) Brushite stone disease as a consequence of lithotripsy? Urol Res 38:293-299
43. Canales BK, Anderson L, Higgins L, Frethem C, Ressler A, Kim IW, Monga M (2009) Proteomic analysis of a matrix stone: a case report. Urol Res 37:323-329
44. Costa-Bauza A, Barcelo C, Perello J, Grases F (2002) Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors. Int Urol Nephrol 34:447-451
45. Pak CYC (1981) Potential etiologic role of brushite in the formation of calcium (renal) stones. J Cryst Growth 53:202-208